Tianjin Chase Sun Pharmaceutical (300026.SZ) Earnings Analysis
Tianjin Chase Sun Pharmaceutical (300026.SZ) has no confirmed upcoming earnings date. Trailing P/E 403.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300026.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300026.SZ. This page updates as the calendar is published.
300026.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | 0.00607 CNY | n/a | n/a | n/a |
| 2025-04-27 | -0.0569 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.02 CNY | n/a | n/a | n/a |
| 2024-10-24 | 0.0067 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.03 CNY | n/a | n/a | n/a |
300026.SZ valuation and analyst view
| Trailing P/E | 403.61 |
|---|---|
| Trailing EPS | 0.00727 CNY |
| Price / book | 1.28 |
| Dividend yield | 0.30% |
| Market cap | 10.03B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Tianjin Chase Sun Pharmaceutical (300026.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300026.SZ. This page updates as the calendar is published.
Did 300026.SZ beat earnings last quarter?
Consensus estimate data was not available for 300026.SZ's 2025-06-30 report.
What is 300026.SZ's current P/E ratio and EPS?
300026.SZ trades at a trailing P/E of 403.61 on trailing EPS of 0.00726783038522863 CNY.
What do analysts rate 300026.SZ?
300026.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.